Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the pricing of its concurrent public offerings of (i) $625,000,000 aggregate principal amount of 0.00% convertible senior notes due 2032 ...

Blue Hat Interactive Entertainment Technology BHAT shares are plunging Friday afternoon after pricing a $6.4 million public offering that adds new shares and warrants. Here’s what investors need to ...

Konik Capital Partners LLC, a division of T.R. Winston & Company, is acting as the sole book-running manager for the offering. MAIA intends to use the net proceeds from the offering to conduct ...

WEST PALM BEACH, FLORIDA / ACCESS Newswire / January 9, 2026 / Ondas Holdings Inc. (NASDAQ:ONDS) ("Ondas" or the "Company"), a leading provider of autonomous aerial and ground robot intelligence ...

Ondas Holdings (ONDS) on Friday announced the pricing of $1B registered direct offering to an institutional investor of 19M shares and, in lieu of common stock, pre-funded warrants to purchase up to ...

SEATTLE, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatments ...

Ondas sold a mix of common shares and pre-funded warrants to a single institutional investor. The transaction covers 60.79 million common stock equivalents under a registered direct offering format.

Arrowhead also granted the underwriters of the note offering a 30-day option to purchase up to an additional $75,000,000 principal amount of notes solely to cover over-allotments and granted the ...